Clinical Trial Update: Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants [Phase 4]

View source ↗

Summary

Phase 4 safety study of Menhycia® in 3-month-old infants is listed as active but not recruiting. The trial is sponsored by CanSino Biologics Inc. and targets ep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidemic Meningitis

Drugs mentioned

• Menhycia®

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Epidemic Meningitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING